TargetMol

SU 23397

Product Code:
 
TAR-T34731
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T34731-5mg5mg£930.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34731-50mg50mg£1,821.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34731-100mg100mg£2,319.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
SU 23397 is a structurally unique neuroleptic agent.
CAS:
37603-15-9
Formula:
C23H27N3O3
Molecular Weight:
393.487
Purity:
0.98
SMILES:
COc1ccc2OC(CN3CCC4(CC3)N(CNC4=O)c3ccccc3)Cc2c1

References

Liebman J, Neale R. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacology (Berl). 1980;68(1):25-9. PubMed PMID: 6104837. Mielke EH, Gallant DM, Bishop G, Kessler CM. Assessment of antipsychotic activity of an unique agent: SU-23397. Psychopharmacol Commun. 1975;1(2):117-22. PubMed PMID: 4858. Chaudhuri NK, Ball TJ, Finch N. The absolute configuration of SU 23397: a novel neuroleptic agent. Experientia. 1977 May 15;33(5):575-7. PubMed PMID: 862771. Angrist BM, Sathananthan G, Thompson H, Gershon S. A clinical trial of a structurally unique neuroleptic (SU-23397). Curr Ther Res Clin Exp. 1975 Aug;18(2):359-63. PubMed PMID: 809249.